Investing in stocks can be risky, but it is also considered one of the most rewarding forms of investment. Initially, as the stock market tends to be sensitive to changes, it may seem like playing with fire because you never know what happens next. But with time and experience, you can comfortably understand the effects of happenings on your stocks, making it easier for you to mitigate any losses.

When investing stocks, you must start with stocks in a somewhat stable industry, just to keep your feet on the ground. You don’t want to deal with too much risk with almost no experience. An industry that is good to do so is the pharmaceutical and health industry. This industry is relatively stable as the health sector is an important part of our society.

A good stock to invest in would be the NASDAQ: BIMI stock at BIMI stands for the stock of BOQI International Medical Inc. founded in 2006. This is a Chinese company that is listed as BIMI in the Nasdaq index on 4th October 2010. It was earlier known as NF Energy Saving Corporation, which was engaged in providing integrated energy conservation solutions, energy management re-engineering projects and technical services.

Currently, the company is providing medical and health care services. BOQI International Medical Inc. has transitioned from being an energy solutions provider to offering a wide range of consumer-oriented health care products and services. The company has a chain of directly owned medical stores that go by the name ‘Boqi Pharmacy’ in China, which sells all kinds of health-related products.

The NASDAQ: BIMI is an overall neutral position stock, perfect for beginners in investing. Looking at the stock technically, it is in a strong sell position, but the market sentiment suggests its position as a strong buy which makes it a neutral stock. The stock has given good returns for the last 5 years, excluding the current situation.

Investing in NASDAQ: BIMI at stock market trading for the short term is advisable as the stock is currently not doing well with little to no change in performance. Also, as limited information is available about the company, proper technical and fundamental analysis is not possible. Right now the stock is showing no growth or profitability, making it not the best choice at the moment.

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Until the pandemic hit, the company’s stock was doing well. In spite of the current dire situations, the company was able to complete the acquisition with Guanzan, as planned. Most of its revenue for the first quarter of 2020 was generated due to this acquisition.


Related Posts

Read also x